Colgate-Palmolive Q2 Earnings Beat on Strong Sales, Margin Expansion

TL;DR

Colgate-Palmolive is crushing it with solid sales and fatter margins, making it a safe bet in a shaky market.

AI Summary

Colgate-Palmolive Co. reported net sales of $4.98 billion for the second quarter ended June 30, 2025, an increase from $4.75 billion in the prior-year quarter. Net income attributable to Colgate-Palmolive Company shareholders rose to $780 million, or $0.94 per diluted share, compared to $720 million, or $0.87 per diluted share, in the second quarter of 2024. The company's gross profit margin improved to 59.5% in Q2 2025 from 58.8% in Q2 2024, driven by favorable pricing and cost savings initiatives. Selling, general, and administrative expenses increased to $1.65 billion from $1.58 billion, primarily due to higher advertising investments. Strategic outlook remains positive with continued focus on premiumization and emerging markets, despite ongoing foreign currency headwinds impacting reported sales. The company also noted a slight increase in long-term debt to $7.5 billion from $7.4 billion at December 31, 2024, reflecting strategic financing activities. Cash and cash equivalents stood at $1.2 billion as of June 30, 2025.

Why It Matters

Colgate-Palmolive's robust Q2 2025 performance, with increased net sales and net income, signals strong brand power and effective cost management in a competitive consumer goods market. This positive trend could reassure investors about the company's ability to navigate inflationary pressures and maintain market share against rivals like Procter & Gamble. For employees, continued growth may translate to job security and potential for advancement, while customers benefit from sustained product innovation and availability. The broader market sees a resilient consumer staple player, indicating underlying stability in household spending despite economic uncertainties.

Risk Assessment

Risk Level: low — Colgate-Palmolive exhibits a low risk profile due to consistent revenue growth, with net sales increasing to $4.98 billion in Q2 2025 from $4.75 billion in Q2 2024, and improved profitability, as evidenced by net income rising to $780 million. The company's strong brand portfolio and global presence provide a stable foundation, mitigating significant operational or market risks.

Analyst Insight

Investors should consider holding or adding to their positions in Colgate-Palmolive, as the company demonstrates consistent financial health and effective management in a stable sector. The improved gross profit margin to 59.5% suggests operational efficiency and pricing power, making it an attractive long-term investment.

Financial Highlights

revenue

$4.98B

total Debt

$7.5B

net Income

$780M

eps

$0.94

gross Margin

59.5%

cash Position

$1.2B

revenue Growth

+4.8%

Key Numbers

• $4.98B — Net Sales (Increased from $4.75B in Q2 2024, showing 4.8% growth.)
• $780M — Net Income (Up from $720M in Q2 2024, representing an 8.3% increase.)
• 59.5% — Gross Profit Margin (Improved from 58.8% in Q2 2024, indicating better cost management.)
• $0.94 — Diluted EPS (Increased from $0.87 in Q2 2024, reflecting higher profitability per share.)
• $1.65B — SG&A Expenses (Increased from $1.58B, driven by higher advertising investments.)
• $7.5B — Long-Term Debt (Slight increase from $7.4B at year-end 2024, reflecting financing activities.)
• $1.2B — Cash and Cash Equivalents (Strong liquidity position as of June 30, 2025.)

Key Players & Entities

• COLGATE PALMOLIVE CO (company) — filer of the 10-Q
• Procter & Gamble (company) — competitor in consumer goods
• $4.98 billion (dollar_amount) — net sales for Q2 2025
• $4.75 billion (dollar_amount) — net sales for Q2 2024
• $780 million (dollar_amount) — net income for Q2 2025
• $720 million (dollar_amount) — net income for Q2 2024
• 59.5% (dollar_amount) — gross profit margin in Q2 2025
• 58.8% (dollar_amount) — gross profit margin in Q2 2024
• $1.65 billion (dollar_amount) — selling, general, and administrative expenses in Q2 2025
• $7.5 billion (dollar_amount) — long-term debt as of June 30, 2025

FAQ

Risk Factors

• Foreign Currency Fluctuations [medium — market]: The company's reported sales are impacted by ongoing foreign currency headwinds. While specific figures for the impact in Q2 2025 are not detailed, this is a recurring factor affecting the translation of international revenues into USD.
• Supply Chain and Input Costs [medium — operational]: While gross profit margin improved to 59.5% in Q2 2025, the company is subject to fluctuations in raw material costs and supply chain disruptions. Effective cost management and pricing strategies are crucial to mitigate these risks.
• Advertising and Marketing Regulations [low — regulatory]: Increased advertising investments, noted as a driver for SG&A expenses, expose the company to evolving regulations regarding marketing practices and claims, particularly in the consumer goods sector.

Industry Context

Colgate-Palmolive operates in the highly competitive global consumer staples market, specifically in oral care, personal care, home care, and pet nutrition. Key trends include a growing demand for premium and sustainable products, increasing penetration in emerging markets, and the ongoing impact of digital channels on consumer engagement and sales. Competitors range from large multinational corporations to smaller, specialized brands, all vying for shelf space and consumer loyalty.

Regulatory Implications

The company must navigate a complex web of regulations concerning product safety, ingredient disclosure, advertising standards, and environmental compliance across its global operations. Increased scrutiny on marketing claims and sustainability initiatives could lead to higher compliance costs or require adjustments to product formulations and communication strategies.

What Investors Should Do

1. [object Object]
2. [object Object]
3. [object Object]
4. [object Object]

Key Dates

• 2025-06-30: End of Second Quarter 2025 — Reporting period for the financial results discussed in the 10-Q, including net sales of $4.98 billion and net income of $780 million.
• 2025-08-01: Filing Date of 10-Q — Indicates the official release of the company's quarterly financial performance and disclosures to the public.
• 2025-06-30: Balance Sheet Date — As of this date, the company reported $1.2 billion in cash and cash equivalents and $7.5 billion in long-term debt.

Glossary

Net Sales

The total revenue generated from the sale of goods and services after deducting returns, allowances, and discounts. (Key indicator of the company's top-line performance and market demand for its products.)

Gross Profit Margin

The percentage of revenue that exceeds the cost of goods sold (COGS). It reflects the company's efficiency in production and pricing power. (An improvement to 59.5% indicates better cost management or stronger pricing, contributing to overall profitability.)

Selling, General, and Administrative (SG&A) Expenses

Costs incurred by a company in the normal course of business, excluding the cost of goods sold and interest expenses. This includes marketing, salaries, and administrative overhead. (An increase to $1.65 billion, driven by advertising, shows investment in brand building and market presence.)

Diluted Earnings Per Share (EPS)

The net income attributable to each share of a company's common stock, including the effect of all dilutive securities such as stock options and convertible bonds. (An increase to $0.94 per share reflects improved profitability on a per-share basis for shareholders.)

Long-Term Debt

Financial obligations that are due more than one year from the balance sheet date. (A slight increase to $7.5 billion suggests strategic financing activities, which need to be monitored in relation to the company's ability to service its debt.)

Year-Over-Year Comparison

Colgate-Palmolive demonstrated solid year-over-year performance in Q2 2025 compared to Q2 2024. Net sales grew by 4.8% to $4.98 billion, and net income saw an 8.3% increase to $780 million, translating to higher diluted EPS of $0.94. The gross profit margin improved to 59.5%, indicating enhanced operational efficiency or pricing power. While SG&A expenses rose due to increased advertising, the overall financial health appears robust, with a strong cash position of $1.2 billion, despite a marginal increase in long-term debt to $7.5 billion.

From the Filing

0000021665-25-000041.txt : 20250801 0000021665-25-000041.hdr.sgml : 20250801 20250801083200 ACCESSION NUMBER: 0000021665-25-000041 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 68 CONFORMED PERIOD OF REPORT: 20250630 FILED AS OF DATE: 20250801 DATE AS OF CHANGE: 20250801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COLGATE PALMOLIVE CO CENTRAL INDEX KEY: 0000021665 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 131815595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-00644 FILM NUMBER: 251174037 BUSINESS ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2123102000 MAIL ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 10-Q 1 cl-20250630.htm 10-Q cl-20250630 0000021665 12/31 2025 Q2 false P5Y 66.67 http://fasb.org/us-gaap/2025#OtherAssetsCurrent http://fasb.org/us-gaap/2025#OtherAssetsCurrent http://fasb.org/us-gaap/2025#OtherAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherAssetsCurrent http://fasb.org/us-gaap/2025#OtherAssetsCurrent http://fasb.org/us-gaap/2025#OtherAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2025#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2025#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2025#SellingGeneralAndAdministrativeExpense 218 xbrli:shares iso4217:USD iso4217:USD xbrli:shares cl:dividend iso4217:AUD cl:countryAndTerritory cl:case cl:segment xbrli:pure 0000021665 2025-01-01 2025-06-30 0000021665 us-gaap:CommonStockMember 2025-01-01 2025-06-30 0000021665 cl:A0.500NotesDue2026Member 2025-01-01 2025-06-30 0000021665 cl:A0300NotesDue2029Member 2025-01-01 2025-06-30 0000021665 cl:A1.375NotesDue2034Member 2025-01-01 2025-06-30 0000021665 cl:A0.875Notesdue2039Member 2025-01-01 2025-06-30 0000021665 2025-06-30 0000021665 2025-04-01 2025-06-30 0000021665 2024-04-01 2024-06-30 0000021665 2024-01-01 2024-06-30 0000021665 2024-12-31 0000021665 2023-12-31 0000021665 2024-06-30 0000021665 us-gaap:CommonStockMember 2025-03-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000021665 us-gaap:TreasuryStockCommonMember 2025-03-31 0000021665 us-gaap:RetainedEarningsMember 2025-03-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0000021665 us-gaap:NoncontrollingInterestMember 2025-03-31 0000021665 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0000021665 us-gaap:NoncontrollingInterestMember 2025-04-01 2025-06-30 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-01 2025-06-30 0000021665 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0000021665 us-gaap:TreasuryStockCommonMember 2025-04-01 2025-06-30 0000021665 us-gaap:CommonStockMember 2025-06-30 0000021665 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0000021665 us-gaap:TreasuryStockCommonMember 2025-06-30 0000021665 us-gaap:RetainedEarningsMember 2025-06-30 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0000021665 us-gaap:NoncontrollingInterestMember 2025-06-30 0000021665 us-gaap:CommonStockMember 2024-03-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000021665 us-gaap:TreasuryStockCommonMember 2024-03-31 0000021665 us-gaap:RetainedEarningsMember 2024-03-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000021665 us-gaap:NoncontrollingInterestMember 2024-03-31 0000021665 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000021665 us-gaap:NoncontrollingInterestMember 2024-04-01 2024-06-30 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0000021665 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 00000216